Misplaced Pages

ATC code C02 Antihypertensives is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup C02 is part of the anatomical group C Cardiovascular system.

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QC02.
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

C02A Antiadrenergic agents, centrally acting

C02AA Rauvolfia alkaloids

C02AA01 Rescinnamine

C02AA02 Reserpine

C02AA03 Combinations of rauwolfia alkaloids

C02AA04 Rauwolfia alkaloids, whole root

C02AA05 Deserpidine

C02AA06 Methoserpidine

C02AA07 Bietaserpine

C02AA52 Reserpine, combinations

C02AA53 Combinations of rauwolfia alkaloids, combinations

C02AA57 Bietaserpine, combinations

C02AB Methyldopa

C02AB01 Methyldopa (levorotatory)

C02AB02 Methyldopa (racemic)

C02AC Imidazoline receptor agonists

C02AC01 Clonidine

C02AC02 Guanfacine

C02AC04 Tolonidine

C02AC05 Moxonidine

C02AC06 Rilmenidine

C02B Antiadrenergic agents, ganglion-blocking

C02BA Sulfonium derivatives

C02BA01 Trimetaphan

C02BB Secondary and tertiary amines

C02BB01 Mecamylamine

C02BC Bisquaternary ammonium compounds

C02C Antiadrenergic agents, peripherally acting

C02CA Alpha-adrenoreceptor antagonists

C02CA01 Prazosin

C02CA02 Indoramin

C02CA03 Trimazosin

C02CA04 Doxazosin

C02CA06 Urapidil

C02CC Guanidine derivatives

C02CC01 Betanidine

C02CC02 Guanethidine

C02CC03 Guanoxan

C02CC04 Debrisoquine

C02CC05 Guanoclor

C02CC06 Guanazodine

C02CC07 Guanoxabenz

C02D Arteriolar smooth muscle, agents acting on

C02DA Thiazide derivatives

C02DA01 Diazoxide

C02DB Hydrazinophthalazine derivatives

C02DB01 Dihydralazine

C02DB02 Hydralazine

C02DB03 Endralazine

C02DB04 Cadralazine

C02DC Pyrimidine derivatives

C02DC01 Minoxidil

C02DD Nitroferricyanide derivatives

C02DD01 Nitroprusside

C02DG Guanidine derivatives

C02DG01 Pinacidil

C02K Other antihypertensives

C02KA Alkaloids, excluding rauwolfia

C02KA01 Veratrum

C02KB Tyrosine hydroxylase inhibitors

C02KB01 Metirosine

C02KC MAO inhibitors

C02KC01 Pargyline

C02KD Serotonin antagonists

C02KD01 Ketanserin

C02KN Other antihypertensives

C02KN01 Aprocitentan

C02KX Antihypertensives for pulmonary arterial hypertension

C02KX01 Bosentan

C02KX02 Ambrisentan

C02KX03 Sitaxentan

C02KX04 Macitentan

C02KX05 Riociguat

C02KX06 Sotatercept

C02KX52 Ambrisentan and tadalafil

C02KX54 Macitentan and tadalafil

C02L Antihypertensives and diuretics in combination

C02LA Rauwolfia alkaloids and diuretics in combination

C02LA01 Reserpine and diuretics

C02LA02 Rescinnamine and diuretics

C02LA03 Deserpidine and diuretics

C02LA04 Methoserpidine and diuretics

C02LA07 Bietaserpine and diuretics

C02LA08 Rauwolfia alkaloids, whole root and diuretics

C02LA09 Syrosingopine and diuretics

C02LA50 Combinations of rauwolfia alkaloids and diuretics including other combinations

C02LA51 Reserpine and diuretics, combinations with other drugs

C02LA52 Rescinnamine and diuretics, combinations with other drugs

C02LA71 Reserpine and diuretics, combinations with psycholeptics

C02LB Methyldopa and diuretics in combination

C02LB01 Methyldopa (levorotatory) and diuretics

C02LC Imidazoline receptor agonists in combination with diuretics

C02LC01 Clonidine and diuretics

C02LC05 Moxonidine and diuretics

C02LC51 Clonidine and diuretics, combinations with other drugs

C02LE Alpha-adrenoreceptor antagonists and diuretics

C02LE01 Prazosin and diuretics

C02LF Guanidine derivatives and diuretics

C02LF01 Guanethidine and diuretics

C02LG Hydrazinophthalazine derivatives and diuretics

C02LG01 Dihydralazine and diuretics

C02LG02 Hydralazine and diuretics

C02LG03 Picodralazine and diuretics

C02LG51 Dihydralazine and diuretics, combinations with other drugs

C02LG73 Picodralazine and diuretics, combinations with psycholeptics

C02LK Alkaloids, excluding rauwolfia, in combination with diuretics

C02LK01 Veratrum and diuretics

C02LL MAO inhibitors and diuretics

C02LL01 Pargyline and diuretics

C02LN Serotonin antagonists and diuretics

C02LX Other antihypertensives and diuretics

C02LX01 Pinacidil and diuretics

C02N Combinations of antihypertensives in ATC-group C02

Empty group

References

1. "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
2. World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
3. "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
4. "ATC/DDD Index 2022: code C02". WHO Collaborating Centre for Drug Statistics Methodology.
5. "ATCvet Index 2022: code QC02". WHO Collaborating Centre for Drug Statistics Methodology.

• ATC codes